Intrinsic value of Radiopharm Theranostics Limited (RADX)
Live fair value data for Radiopharm Theranostics Limited (RADX) is currently unavailable. Please check again shortly.
Current Price: $163.00
Valuation: Undervalued
Confidence: 9.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Radiopharm Theranostics Limited (RADX) undervalued or overvalued?
Based on the current model output, Radiopharm Theranostics Limited appears to be undervalued with a upside of 71.00%.
Fair value vs market price — Radiopharm Theranostics Limited (RADX)
Unlock premium access to view the live fair value comparison against current market price for RADX.
Frequently Asked Questions - RADX
How is RADX intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for RADX.
Is RADX undervalued or overvalued right now?
RADX is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for RADX: open their intrinsic value pages.